Thomas J. van Rijssen

Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial

Thomas J. van Rijssen, Elon H. C. van Dijk, Roula Tsonaka et al. · American Journal of Ophthalmology · 2021 · 92 citations

Ophthalmology, Photodynamic Therapy, Medicine +4

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy

Danial Mohabati, Thomas J. van Rijssen, Elon Van Dijk et al. · Clinical ophthalmology · 2018 · 62 citations · Full text

Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach

Elon H. C. van Dijk, Thomas J. van Rijssen, Yousif Subhi et al. · Ophthalmology and Therapy · 2020 · 62 citations · Full text

Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3

Thomas J. van Rijssen, Elon H. C. van Dijk, Paula Scholz et al. · American Journal of Ophthalmology · 2019 · 59 citations

Subthreshold Micropulse Laser, Radiology, Half-dose Photodynamic Therapy +1

Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial

Thomas J. van Rijssen, Elon H. C. van Dijk, Paula Scholz et al. · American Journal of Ophthalmology · 2020 · 49 citations · Full text